Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome - No Study Results Posted

Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome (MATOCSS)

This study is ongoing, but not recruiting participants.

Study NCT00527566 Information provided by Brigham and Women's Hospital

First Received: September 7, 2007 Last Updated: April 16, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2009
Estimated Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)